MCE 的所有產(chǎn)品僅用作科學(xué)研究，我們不為任何個人用途提供產(chǎn)品和服務(wù)。

Piperlongumine

CAS No. : 20069-09-4

MCE 國際站：Piperlongumine

產(chǎn)品活性：Piperlongumine 是從蓽茇中得到的生物堿，具有抗炎、抗菌、抗血管生成、抗氧化、抗腫瘤和抗糖尿病等活性。在腫瘤細(xì)胞中，Piperlongumine 能夠誘導(dǎo) ROS 和凋亡。Piperlongumine 具有抗心肌纖維化的作用，通過抑制 ERK1/2 信號通路抑制肌成纖維細(xì)胞的轉(zhuǎn)化。

研究領(lǐng)域：MAPK/ERK Pathway  |  Stem Cell/Wnt  |  Immunology/Inflammation  |  NF-κB  |  Metabolic Enzyme/Protease  |  Autophagy  |  Anti-infection  |  Apoptosis

作用靶點：ERK  |  Ferroptosis  |  Reactive Oxygen Species  |  Autophagy  |  Bacterial  |  Apoptosis

In Vitro: Piplartine (5, 10, and 15 μM) significantly decreases cell proliferation of 786-O, SKBR3, Panc1, A549, and L3.6pL cancer cells after treatment for 24 and 48 hours, induces apoptosis and ROS in these cell lines at 5 and 10 μM after 3 or 9 h of treatment.

Piplartine (5 or 10 μM) induces cleaved PARP and downregulates Sp1, Sp3, Sp4, and Sp-regulated genes.

Piplartine (20 μM) decreases the viability of cardiac fibroblasts (CFs). Piplartine (0-10 μM) suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway.

In Vivo: Piperlongumine (30 mg/kg/day, i.p. for 3 weeks) exhibits potent anti-tumor effect in athymic nude mice bearing L3.6pL cells without body weight loss.

相關(guān)產(chǎn)品：Apoptosis Compound Library  |  Anti-Infection Compound Library  |  Natural Product Library Plus  |  Reprogramming Compound Library  |  Antioxidants Compound Library  |  NF-κB Signaling Compound Library  |  Kinase Inhibitor Library  |  Oxygen Sensing Compound Library  |  Natural Product Library  |  Stem Cell Signaling Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Ferroptosis Compound Library  |  Anti-Cancer Compound Library  |  Metabolism/Protease Compound Library  |  Bioactive Compound Library Plus  |  Autophagy Compound Library  |  Immunology/Inflammation Compound Library  |  MAPK Compound Library  |  Anti-Bacterial Compound Library  |  Diabetes Related Compound Library  |  Cycloheximide  |  LY294002  |  Cisplatin  |  Doxorubicin hydrochloride  |  Y-27632 dihydrochloride  |  SP600125  |  Erastin  |  Puromycin Dihydrochloride  |  Sorafenib  |  Ferrostatin-1  |  H2DCFDA  |  Trametinib  |  Pexidartinib  |  Tamoxifen  |  Bortezomib  |  BAY 11-7082  |  ML385  |  Necrostatin-1  |  Decitabine  |  Acetylcysteine  |  Temozolomide  |  Docetaxel  |  Deferoxamine mesylate  |  2-Deoxy-D-glucose  |  Dasatinib  |  DAPT  |  Etoposide  |  Tunicamycin  |  SCH772984  |  Mdivi-1

品牌介紹:
•   MCE (MedChemExpress) 擁有數(shù)百種全球獨家化合物，我們致力于為全球科研客戶提供最新最全的高品質(zhì)小分子活性化合物；
•   10,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)域；
•   設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球最新的活性化合物；
•   與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長期的合作。